(Q39230390)

10 September 2017

title

The immunology of atherosclerosis (English)

1 reference

10 September 2017

1 reference

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

author name string

Göran K Hansson

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

language of work or name

English

0 references

publication date

10 April 2017

1 reference

Nature Reviews Nephrology

10 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

5 June 2020

page(s)

368-380

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/nrneph.2017.51

5 June 2020

exact match

0 references

cites work

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Chronic kidney disease: effects on the cardiovascular system

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Screening and risk stratification of coronary artery disease in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inflammation, atherosclerosis, and coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Subendothelial retention of atherogenic lipoproteins in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The response-to-retention hypothesis of early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Progress and challenges in translating the biology of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The immune system in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T lymphocytes from human atherosclerotic plaques recognize oxidized low density lipoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transgenic human C-reactive protein is not proatherogenic in apolipoprotein E-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transgenic human CRP is not pro-atherogenic, pro-atherothrombotic or pro-inflammatory in apoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Novel methodologies for biomarker discovery in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Plasma pentraxin 3 in patients with chronic kidney disease: associations with renal function, protein-energy wasting, cardiovascular disease, and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The long pentraxin PTX3: a modulator of the immunoinflammatory response in atherosclerosis and cardiovascular diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Regulation of leukocyte recruitment by the long pentraxin PTX3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Deficiency of the Long Pentraxin PTX3 Promotes Vascular Inflammation and Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Infection with Chlamydia pneumoniae accelerates the development of atherosclerosis and treatment with azithromycin prevents it in a rabbit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Chlamydia pneumoniae infection does not induce or modify atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Infectious agents are not necessary for murine atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effects of antibiotic therapy on outcomes of patients with coronary artery disease: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

A genome-wide association study for coronary artery disease identifies a novel susceptibility locus in the major histocompatibility complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

MHC2TA is associated with differential MHC molecule expression and susceptibility to rheumatoid arthritis, multiple sclerosis and myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Modified LDL - trigger of atherosclerosis and inflammation in the arterial intima

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Endothelial expression of a mononuclear leukocyte adhesion molecule during atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

High-resolution imaging of intravascular atherogenic inflammation in live mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Live cell imaging to understand monocyte, macrophage, and dendritic cell function in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Local proliferation dominates lesional macrophage accumulation in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein, producing massive cholesterol deposition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Macrophages in atherosclerosis: a dynamic balance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Scavenger receptors class A-I/II and CD36 are the principal receptors responsible for the uptake of modified low density lipoprotein leading to lipid loading in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Fluorescent pegylated nanoparticles demonstrate fluid-phase pinocytosis by macrophages in mouse atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

M-1/M-2 macrophages and the Th1/Th2 paradigm

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Human atherosclerotic plaque alternative macrophages display low cholesterol handling but high phagocytosis because of distinct activities of the PPARγ and LXRα pathways.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Identification of a novel macrophage phenotype that develops in response to atherogenic phospholipids via Nrf2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transdifferentiation of mouse aortic smooth muscle cells to a macrophage-like state after cholesterol loading

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transdifferentiation of vascular smooth muscle cells to macrophage-like cells during atherogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

KLF4-dependent phenotypic modulation of smooth muscle cells has a key role in atherosclerotic plaque pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Contribution of intimal smooth muscle cells to cholesterol accumulation and macrophage-like cells in human atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lessons from sudden coronary death: a comprehensive morphological classification scheme for atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Time-Dependent Changes in Atherosclerotic Plaque Composition in Patients Undergoing Carotid Surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The collagen cross-linking enzyme lysyl oxidase is associated with the healing of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interferon gamma inhibits both proliferation and expression of differentiation-specific alpha-smooth muscle actin in arterial smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T-cell activation leads to reduced collagen maturation in atherosclerotic plaques of Apoe(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Matrix metalloproteinases in atherothrombosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Spotty calcification typifies the culprit plaque in patients with acute myocardial infarction: an intravascular ultrasound study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Minimally modified LDL binds to CD14, induces macrophage spreading via TLR4/MD-2, and inhibits phagocytosis of apoptotic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Oxidative stress induces angiogenesis by activating TLR2 with novel endogenous ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Innate immune signals in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Phospholipase A(2) in vascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Homocysteine lowering with folic acid and B vitamins in people with chronic kidney disease--results of the renal Hope-2 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Darapladib for Preventing Ischemic Events in Stable Coronary Heart Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effect of darapladib on major coronary events after an acute coronary syndrome: the SOLID-TIMI 52 randomized clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Proliferating or interleukin 1-activated human vascular smooth muscle cells secrete copious interleukin 6.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inflammatory markers at the site of ruptured plaque in acute myocardial infarction: locally increased interleukin-6 and serum amyloid A but decreased C-reactive protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Depletion of natural killer cell function decreases atherosclerosis in low-density lipoprotein receptor null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Gammadelta (γδ) T lymphocytes do not impact the development of early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Deleting TCR alpha beta+ or CD4+ T lymphocytes leads to opposite effects on site-specific atherosclerosis in female apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Expression of class II transplantation antigen on vascular smooth muscle cells in human atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Mapping of vascular dendritic cells in atherosclerotic arteries suggests their involvement in local immune-inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Emigration of monocyte-derived cells from atherosclerotic lesions characterizes regressive, but not progressive, plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Low density lipoprotein undergoes oxidative modification in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Identification of immune responses against aldehyde-modified peptide sequences in apoB associated with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Human 60-kDa heat shock protein is a target autoantigen of T cells derived from atherosclerotic plaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Autoantibodies against heat shock protein 60 mediate endothelial cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The role of heat shock proteins in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Mucosal administration of heat shock protein-65 decreases atherosclerosis and inflammation in aortic arch of low-density lipoprotein receptor-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lymphotoxin beta receptor signaling promotes tertiary lymphoid organogenesis in the aorta adventitia of aged ApoE-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lymphatic vasculature mediates macrophage reverse cholesterol transport in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Induction of indoleamine 2,3-dioxygenase in vascular smooth muscle cells by interferon-gamma contributes to medial immunoprivilege

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Artery Tertiary Lymphoid Organs Control Aorta Immunity and Protect against Atherosclerosis via Vascular Smooth Muscle Cell Lymphotoxin β Receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Control of the T follicular helper-germinal center B-cell axis by CD8⁺ regulatory T cells limits atherosclerosis and tertiary lymphoid organ development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Adoptive transfer of CD4+ T cells reactive to modified low-density lipoprotein aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lymphocytes are important in early atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The effects of total lymphocyte deficiency on the extent of atherosclerosis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inhibition of T cell response to native low-density lipoprotein reduces atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

IFN-gamma potentiates atherosclerosis in ApoE knock-out mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

IFN-gamma deficiency exerts gender-specific effects on atherogenesis in apolipoprotein E-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Influence of interferon-gamma on the extent and phenotype of diet-induced atherosclerosis in the LDLR-deficient mouse

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Ia expression by vascular endothelium is inducible by activated T cells and by human gamma interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Gene expression signatures, pathways and networks in carotid atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Hypercholesterolemia is associated with a T helper (Th) 1/Th2 switch of the autoimmune response in atherosclerotic apo E-knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The role of interleukin-4 and interleukin-12 in the progression of atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-4 deficiency decreases atherosclerotic lesion formation in a site-specific manner in female LDL receptor-/- mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-13 protects from atherosclerosis and modulates plaque composition by skewing the macrophage phenotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

IL-33 reduces the development of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Large-scale gene-centric analysis identifies novel variants for coronary artery disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Proatherogenic conditions promote autoimmune T helper 17 cell responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Induction of intestinal Th17 cells by segmented filamentous bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

A critical function of Th17 proinflammatory cells in the development of atherosclerotic plaque in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Loss of SOCS3 expression in T cells reveals a regulatory role for interleukin-17 in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inhibition of IL-17A in atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transforming growth factor-β signaling in T cells promotes stabilization of atherosclerotic plaques through an interleukin-17-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The Th17/Treg imbalance in patients with acute coronary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Low numbers of FOXP3 positive regulatory T cells are present in all developmental stages of human atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Dynamic changes in regulatory T cells are linked to levels of diet-induced hypercholesterolemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Depletion of FOXP3+ regulatory T cells promotes hypercholesterolemia and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cytokine therapy with interleukin-2/anti-interleukin-2 monoclonal antibody complexes expands CD4+CD25+Foxp3+ regulatory T cells and attenuates development and progression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Oral administration of an active form of vitamin D3 (calcitriol) decreases atherosclerosis in mice by inducing regulatory T cells and immature dendritic cells with tolerogenic functions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Oral anti-CD3 antibody treatment induces regulatory T cells and inhibits the development of atherosclerosis in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Regression of atherosclerosis with anti-CD3 antibody via augmenting a regulatory T-cell response in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Differential effects of regulatory T cells on the initiation and regression of atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Disruption of TGF-β signaling in T cells accelerates atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inhibition of transforming growth factor-beta signaling accelerates atherosclerosis and induces an unstable plaque phenotype in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

TGF-[beta]1 limits plaque growth, stabilizes plaque structure, and prevents aortic dilation in apolipoprotein E-null mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Overexpression of TGF-ß1 in macrophages reduces and stabilizes atherosclerotic plaques in ApoE-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Elevated systemic TGF-beta impairs aortic vasomotor function through activation of NADPH oxidase-driven superoxide production and leads to hypertension, myocardial remodeling, and increased plaque formation in apoE(-/-) mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Protective immunity against atherosclerosis carried by B cells of hypercholesterolemic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

B-lymphocyte deficiency increases atherosclerosis in LDL receptor-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Splenectomy and subsequent mortality in veterans of the 1939-45 war.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

B cell depletion reduces the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Conventional B2 B cell depletion ameliorates whereas its adoptive transfer aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effects of rituximab treatment on endothelial dysfunction, carotid atherosclerosis, and lipid profile in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

B1a B lymphocytes are atheroprotective by secreting natural IgM that increases IgM deposits and reduces necrotic cores in atherosclerotic lesions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Apoptotic cells with oxidation-specific epitopes are immunogenic and proinflammatory

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Sterile inflammation in the spleen during atherosclerosis provides oxidation-specific epitopes that induce a protective B-cell response

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inflammation and metabolic disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Changes in serum lipoprotein pattern induced by acute infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cachectin and tumour necrosis factor as two sides of the same biological coin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

LXR signaling couples sterol metabolism to proliferation in the acquired immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Rapid increase in myocardial infarction risk following diagnosis of rheumatoid arthritis amongst patients diagnosed between 1995 and 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The microbial metabolites, short-chain fatty acids, regulate colonic Treg cell homeostasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Short-chain fatty acids induce both effector and regulatory T cells by suppression of histone deacetylases and regulation of the mTOR-S6K pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The gut microbiota--masters of host development and physiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cyclosporin A inhibits smooth muscle proliferation in the vascular response to injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Bench to bedside: the development of rapamycin and its application to stent restenosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Anti-inflammatory therapies for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

LDL immunization induces T-cell-dependent antibody formation and protection against atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Vaccination against T-cell epitopes of native ApoB100 reduces vascular inflammation and disease in a humanized mouse model of atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Induction of oral tolerance to oxidized low-density lipoprotein ameliorates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T cell-based therapies for atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Relationship of IgG and IgM autoantibodies to oxidized low density lipoprotein with coronary artery disease and cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

FDG-PET imaging for oxidized LDL in stable atherosclerotic disease: a phase II study of safety, tolerability, and anti-inflammatory activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The role of innate immunity in atherogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Recombinant human antibodies against aldehyde-modified apolipoprotein B-100 peptide sequences inhibit atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Identification of a danger-associated peptide from apolipoprotein B100 (ApoBDS-1) that triggers innate proatherogenic responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The LDL modification hypothesis of atherogenesis: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

In vivo MHC class II presentation of cytosolic proteins revealed by rapid automated tandem mass spectrometry and functional analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Circulating levels of interleukin-17 and cardiovascular outcomes in patients with acute myocardial infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Natural regulatory T cells control the development of atherosclerosis in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Regulatory T-Cell Response to Apolipoprotein B100–Derived Peptides Reduces the Development and Progression of Atherosclerosis in Mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Protective Role of Interleukin-10 in Atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

The Prognostic Value of C-Reactive Protein and Serum Amyloid A Protein in Severe Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Elevated Levels of Interleukin-6 in Unstable Angina

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure

21 January 2018

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

31 March 2020

12 December 2020

Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Genetics of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Regional accumulations of T cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Influence of plaque configuration and stress distribution on fissuring of coronary atherosclerotic plaques

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Site of intimal rupture or erosion of thrombosed coronary atherosclerotic plaques is characterized by an inflammatory process irrespective of the dominant plaque morphology

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Assessment of culprit lesion morphology in acute myocardial infarction: ability of optical coherence tomography compared with intravascular ultrasound and coronary angioscopy

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Infiltrates of activated mast cells at the site of coronary atheromatous erosion or rupture in myocardial infarction

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Expression of toll-like receptors in human atherosclerotic lesions: a possible pathway for plaque activation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-1β inhibition and the prevention of recurrent cardiovascular events: rationale and design of the Canakinumab Anti-inflammatory Thrombosis Outcomes Study (CANTOS)

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Hyperlipidemia-Triggered Neutrophilia Promotes Early Atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effect of natural killer T cell activation on the initiation of atherosclerosis.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Autoantibody titers to oxidized low-density lipoprotein in patients with coronary atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Lysophosphatidylcholine Is Involved in the Antigenicity of Oxidized LDL

31 March 2020

2 references

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

31 March 2020

12 December 2020

Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Subcutaneous immunization with heat shock protein-65 reduces atherosclerosis in Apoe−/− mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Adoptive transfer of beta(2)-glycoprotein I-reactive lymphocytes enhances early atherosclerosis in LDL receptor-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Immunization of apoE-/- mice with aldehyde-modified fibronectin inhibits the development of atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Distribution of inflammatory cells in adventitia changed with advancing atherosclerosis of human coronary artery

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Oligoclonal T cell expansions in atherosclerotic lesions of apolipoprotein E-deficient mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transfer of CD4(+) T cells aggravates atherosclerosis in immunodeficient apolipoprotein E knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-17A Deficiency Accelerates Unstable Atherosclerotic Plaque Formation in Apolipoprotein E-Deficient Mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Evidence for a role of regulatory T cells in mediating the atheroprotective effect of apolipoprotein B peptide vaccine

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-10 blocks atherosclerotic events in vitro and in vivo

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Interleukin-10 deficiency increases atherosclerosis, thrombosis, and low-density lipoproteins in apolipoprotein E knockout mice.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Transforming growth factor-beta mediates balance between inflammation and fibrosis during plaque progression

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Detection of B cells and proinflammatory cytokines in atherosclerotic plaques of hypercholesterolaemic apolipoprotein E knockout mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Atherosclerosis Susceptibility in Mice Is Independent of the V1 Immunoglobulin Heavy Chain Gene

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Cardiovascular morbidity and mortality associated with the metabolic syndrome

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effects of biologics on vascular function and atherosclerosis associated with rheumatoid arthritis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Atheroprotective Vaccination with MHC-II Restricted Peptides from ApoB-100.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Immunotherapy with tolerogenic apolipoprotein B-100-loaded dendritic cells attenuates atherosclerosis in hypercholesterolemic mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

T lymphocytes in human atherosclerotic plaques are memory cells expressing CD45RO and the integrin VLA-1

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

7 January 2021

inferred from DOI database lookup

Differential expression of interleukin-17 family cytokines in intact and complicated human atherosclerotic plaques.

1 reference

https://api.crossref.org/works/10.1038%2FNRNEPH.2017.51

7 January 2021

inferred from DOI database lookup

Inflammation, malnutrition, and cardiac disease as predictors of mortality in hemodialysis patients

1 reference

12 December 2020

Measurement of serum C-reactive protein concentration in myocardial ischaemia and infarction

1 reference

12 December 2020

The M1 and M2 paradigm of macrophage activation: time for reassessment

1 reference

12 December 2020

Weak associations between human leucocyte antigen genotype and acute myocardial infarction

1 reference

12 December 2020

Detection of activated T lymphocytes in the human atherosclerotic plaque

1 reference

12 December 2020

Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritis

1 reference

12 December 2020

CD36 modulates migration of mouse and human macrophages in response to oxidized LDL and may contribute to macrophage trapping in the arterial intima

1 reference

12 December 2020

Requiem for the 'vulnerable plaque'

1 reference

12 December 2020

Characterization of lipid-laden aortic cells from cholesterol-fed rabbits. IV. Investigation of macrophage-like properties of aortic cell populations

1 reference

12 December 2020

Evidence for a local immune response in atherosclerosis. CD4+ T cells infiltrate lesions of apolipoprotein-E-deficient mice

1 reference

12 December 2020

Inhibition of atherosclerosis in CD4 T-cell-ablated and nude (nu/nu) C57BL/6 hyperlipidemic mice

1 reference

12 December 2020

Recombinant interleukin 6 regulates the transcriptional activation of a set of human acute phase genes.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRNEPH.2017.51

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28392564%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

5 June 2020

1084738856

0 references

Fatcat ID

release_yaulhlbbzrfv5kisvstzm37hl4

0 references

1 reference